Abu Dhabi: The Department of Health – Abu Dhabi (DoH) has successfully concluded a strategic delegation visit to Russia, fostering collaborations in healthcare innovation, precision medicine, genomics, and longevity research.
According to Emirates News Agency, the delegation engaged with senior officials, leading research centres, and industry pioneers, aligning with Abu Dhabi’s vision to build one of the world’s most intelligent and integrated healthcare systems while positioning the emirate as a global hub for life sciences and medical innovation.
Led by Dr. Noura Al Ghaithi, Under-Secretary of the Department of Health – Abu Dhabi (DoH), the delegation met with Mikhail Murashko, Russian Minister of Health, to explore avenues for collaboration in vaccine development, medical education, genomics, and research.
The Abu Dhabi delegation also met with prominent Russian institutions, including Sechenov University, the Moscow Institute of Physics and Technology (MIPT), the Dmitry Rogachev National Research Cent
re, and the Gamaleya National Research Centre, to explore opportunities for academic exchanges, joint research initiatives, and medical education programmes.
The discussions highlighted the potential for conducting clinical trials for the newly developed cancer vaccine and enhancing collaboration in genomics, precision medicine, oncology, and capacity building in communicable diseases. Additionally, the delegation engaged with several Emirati medical students enrolled at leading Russian universities.
The delegation explored strategic partnerships with Russia’s leading healthcare facilities, including the Medsi Group, the National Medical Center of Oncology (N.N. Blokhin Cancer Center), and the Marshak Clinic. These discussions focused on advanced treatment protocols, rehabilitation services, addiction treatment, and mental healthcare, and opportunities to enhance patient care and treatment outcomes.
Recognising the critical role of innovation in shaping the future of healthcare, the delegation met with the
Skolkovo Innovation Centre, Russia’s leading technology hub, and Biocad Pharmaceutical Company, a prominent biotech and pharmaceutical organisation. The discussions explored collaboration opportunities with biotech and medtech initiatives in Abu Dhabi, strengthening drug availability, particularly in gene therapy and advanced treatment options, and fostering innovation in digital health and precision medicine.
Commenting on the success of the visit, Dr. Noura Al Ghaithi stated, ‘This mission marks a significant milestone in Abu Dhabi’s commitment to advancing global healthcare collaboration. Through our engagements with Russia’s leading institutions, we have identified key areas for joint research and innovation. This initiative paves the way for long-term partnerships that will drive excellence in medical research and healthcare delivery for communities around all the world.’
The delegation also extended an official invitation to Russian healthcare leaders to participate in the upcoming Abu Dhabi Global He
alth Week 2025, reinforcing global cooperation in life sciences and medical research. This premier event will provide a platform for knowledge exchange, strategic networking, and investment opportunities, allowing Russian experts to showcase their innovations while gaining insights into Abu Dhabi’s cutting-edge healthcare advancements and regulatory frameworks.